NHWD-870 protects the kidney from ischemia/reperfusion injury by upregulating the PI3K/AKT signaling pathway (experimental study)
Related Experiment Video
Updated: Jul 17, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Saba Sahib Younis1, Fadhaa Abdul Ameer Ghafil2, Sahar Majeed2
1Al-Sadr Medical City, Al-Najaf Health Directorate, Al Najaf Al-Ashraf, Iraq.
Abstract:
Renal ischemia-reperfusion injury is a critical clinical condition with a potentially fatal prognosis if not adequately managed. NHWD-870, a known Brd4 inhibitor with anti-cancer properties, exhibits additional attributes such as antioxidant, anti-inflammatory, and anti-apoptotic effects, suggesting its potential to preserve renal tissue and mitigate damage during ischemic insults. We aimed to assess the potential nephroprotective effect of NHWD-870 by investigating its anti-apoptotic, anti-inflammatory, and antioxidant properties in a rat model of renal ischemia-reperfusion injury. Male Wistar Albino rats (n=24) were randomly assigned to four groups: sham, control, vehicle, and NHWD-870. The control group experienced bilateral renal ischemia for 30 minutes, followed by 2 hours of reperfusion, while the sham group underwent a laparotomy without ischemia-reperfusion induction. The vehicle group received a DMSO injection, and the NHWD-870 group was administered 3mg/kg NHWD-870 orally 24 hours before repeating the control group protocol. Blood samples were collected after reperfusion for blood urea nitrogen (BUN) and serum creatinine (SCr) analysis. ELISA method was used to assess IL-1B, BCL-2, PGF-2, and PI3K/AKT signaling pathways in renal tissue. Tubular injury severity was evaluated through histopathological analysis. NHWD-870 treatment improved renal function and histological preservation compared to the control and vehicle groups. BUN, sCR, IL-1B, BCL-2, and PGF-2 levels in renal tissue were significantly improved in the NHWD-870 group (p<0.05). Furthermore, the PI3K/AKT signaling pathway was significantly upregulated (p<0.01), and tubular injury severity was reduced in the NHWD-870 group. NHWD-870 demonstrated substantial nephroprotective effects in reducing renal damage induced by ischemia-reperfusion injury in rats. These effects may be attributed to the anti-apoptotic properties, as indicated by increased levels of the anti-apoptotic protein Bcl-2, and the reduction in oxidative stress marker PGF-2 through upregulation of the PI3K/AKT signaling pathway, along with the decrease in the inflammatory marker IL-1B.
Insights
NHWD-870, a Brd4 inhibitor, shows significant nephroprotective effects against renal ischemia-reperfusion injury in rats. It reduces kidney damage by decreasing inflammation and oxidative stress, preserving renal function and tissue integrity.
Area of Science:
- Nephrology
- Pharmacology
- Molecular Biology
Background:
- Renal ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury.
- NHWD-870, a Brd4 inhibitor, possesses antioxidant, anti-inflammatory, and anti-apoptotic properties.
- These properties suggest NHWD-870's potential for mitigating IRI-induced renal damage.
Purpose of the Study:
- To evaluate the nephroprotective effects of NHWD-870 in a rat model of renal IRI.
- To investigate the underlying anti-apoptotic, anti-inflammatory, and antioxidant mechanisms of NHWD-870.
Main Methods:
- Male Wistar Albino rats were subjected to 30 minutes of bilateral renal ischemia and 2 hours of reperfusion.
- NHWD-870 (3mg/kg) was administered orally 24 hours prior to the IRI procedure.
- Renal function was assessed by blood urea nitrogen (BUN) and serum creatinine (SCr).
- Inflammatory marker (IL-1β), apoptotic markers (Bcl-2), oxidative stress marker (PGF-2), and PI3K/AKT pathway were analyzed using ELISA.
- Renal tissue damage was evaluated through histopathology.
Main Results:
- NHWD-870 treatment significantly improved renal function, indicated by reduced BUN and SCr levels.
- Histopathological analysis revealed reduced tubular injury severity in the NHWD-870 group.
- NHWD-870 administration led to decreased levels of IL-1β and PGF-2, and increased Bcl-2 levels in renal tissue.
- The PI3K/AKT signaling pathway was significantly upregulated following NHWD-870 treatment.
Conclusions:
- NHWD-870 demonstrates significant nephroprotective effects against renal IRI in rats.
- These protective effects are likely mediated by its anti-apoptotic (via Bcl-2), anti-inflammatory (via IL-1β reduction), and antioxidant (via PGF-2 reduction) properties.
- Upregulation of the PI3K/AKT pathway contributes to the observed renoprotection by NHWD-870.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
PI3K/mTOR/AKT Signaling Pathway
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
The JAK-STAT Signaling Pathway
Acute Kidney Injury I: Introduction

